| Year |
Citation |
Score |
| 2023 |
Jung HS, Suknuntha K, Kim YH, Liu P, Dettle ST, Sedzro DM, Smith PR, Thomson JA, Ong IM, Slukvin II. SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways. Iscience. 26: 106621. PMID 37250328 DOI: 10.1016/j.isci.2023.106621 |
0.782 |
|
| 2022 |
Zhang J, Webster S, Duffin B, Bernstein MN, Steill J, Swanson S, Forsberg MH, Bolin J, Brown ME, Majumder A, Capitini CM, Stewart R, Thomson JA, Slukvin II. Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies. Stem Cell Reports. PMID 36638788 DOI: 10.1016/j.stemcr.2022.12.012 |
0.374 |
|
| 2022 |
Weinfurter JT, D'Souza SS, Matschke LM, Bennett S, Kelnhofer-Millevolte LE, Suknuntha K, Kumar A, Coonen J, Capitini CM, Hematti P, Golos TG, Slukvin II, Reynolds MR. Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques. Scientific Reports. 12: 12345. PMID 35853970 DOI: 10.1038/s41598-022-16306-z |
0.715 |
|
| 2022 |
Uenishi GI, Jung HS, Slukvin II. Assessment of Endothelial-to-Hematopoietic Transition of Individual Hemogenic Endothelium and Bulk Populations in Defined Conditions. Methods in Molecular Biology (Clifton, N.J.). 2429: 103-124. PMID 35507158 DOI: 10.1007/978-1-0716-1979-7_8 |
0.493 |
|
| 2022 |
D'Souza SS, Kumar A, Maufort J, Weinfurter JT, Raymond M, Strelchenko N, Perrin E, Coonen J, Mejia A, Simmons H, Torbett BE, Reynolds M, Thomson JA, Slukvin I. Assessment of Safety and Immunogenicity of MHC homozygous iPSC-derived CD34+ Hematopoietic Progenitors in a NHP Model. Blood Advances. PMID 35404997 DOI: 10.1182/bloodadvances.2022006984 |
0.474 |
|
| 2022 |
D'Souza SS, Kumar A, Weinfurter J, Park MA, Maufort J, Tao L, Kang H, Dettle ST, Golos T, Thomson JA, Reynolds MR, Slukvin I. Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus. Stem Cell Reports. PMID 35364011 DOI: 10.1016/j.stemcr.2022.03.003 |
0.377 |
|
| 2021 |
Jung HS, Uenishi G, Park MA, Liu P, Suknuntha K, Raymond M, Choi YJ, Thomson JA, Ong IM, Slukvin II. SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis. Cell Reports. 34: 108758. PMID 33596423 DOI: 10.1016/j.celrep.2021.108758 |
0.746 |
|
| 2020 |
Kumar A, D'Souza SS, Uenishi G, Park MA, Lee JH, Slukvin II. Generation of T cells from Human and Nonhuman Primate Pluripotent Stem Cells. Bio-Protocol. 10: e3675. PMID 33659345 DOI: 10.21769/BioProtoc.3675 |
0.454 |
|
| 2020 |
Suknuntha K, Choi YJ, Jung HS, Majumder A, Shah S, Slukvin I, Ranheim EA. Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition. Frontiers in Oncology. 10: 585151. PMID 33363015 DOI: 10.3389/fonc.2020.585151 |
0.689 |
|
| 2020 |
D'Souza SS, Bennett S, Kumar A, Kelnhofer LE, Weinfurter J, Suknuntha K, Coonen J, Mejia A, Simmons H, Golos T, Hematti P, Capitini CM, Reynolds MR, Slukvin II. Transplantation of TCRα/β-depleted allogeneic bone marrow in nonhuman primates. Experimental Hematology. PMID 33176119 DOI: 10.1016/j.exphem.2020.09.198 |
0.718 |
|
| 2020 |
Majumder A, Suknuntha K, Bennin D, Klemm L, Brok-Volchanskaya VS, Huttenlocher A, Slukvin I. Generation of Human Neutrophils from Induced Pluripotent Stem Cells in Chemically Defined Conditions Using Modified mRNA. Star Protocols. 1. PMID 33043305 DOI: 10.1016/j.xpro.2020.100075 |
0.742 |
|
| 2020 |
Bloor AJC, Patel A, Griffin JE, Gilleece MH, Radia R, Yeung DT, Drier D, Larson LS, Uenishi GI, Hei D, Kelly K, Slukvin I, Rasko JEJ. Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nature Medicine. PMID 32929265 DOI: 10.1038/S41591-020-1050-X |
0.453 |
|
| 2019 |
Brok-Volchanskaya VS, Bennin DA, Suknuntha K, Klemm LC, Huttenlocher A, Slukvin I. Effective and Rapid Generation of Functional Neutrophils from Induced Pluripotent Stem Cells Using ETV2-Modified mRNA. Stem Cell Reports. PMID 31708474 DOI: 10.1016/J.Stemcr.2019.10.007 |
0.772 |
|
| 2019 |
Ozog S, Timberlake ND, Hermann K, Garijo O, Haworth KG, Shi G, Glinkerman CM, Schefter LE, D'Souza S, Simpson E, Sghia-Hughes G, Carillo RR, Boger DL, Kiem HP, Slukvin I, et al. Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes. Blood. PMID 31416800 DOI: 10.1182/Blood.2019000040 |
0.49 |
|
| 2019 |
Mesquitta WT, Wandsnider M, Kang H, Thomson J, Moskvin O, Suknuntha K, Slukvin II. UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells. Scientific Reports. 9: 6622. PMID 31036928 DOI: 10.1038/S41598-019-43054-4 |
0.774 |
|
| 2019 |
Ozay EI, Vijayaraghavan J, Gonzalez-Perez G, Shanthalingam S, Sherman HL, Garrigan DT, Chandiran K, Torres JA, Osborne BA, Tew GN, Slukvin II, Macdonald RA, Kelly K, Minter LM. Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease. Stem Cell Research. 35: 101401. PMID 30738321 DOI: 10.1016/J.Scr.2019.101401 |
0.472 |
|
| 2019 |
Jung HS, Uenishi GI, Park MA, Liu P, Raymond M, Thomson J, Ong I, Slukvin I. SOX17 Is Essential for Integration of Arterial and HOXA Programs in Hemogenic Endothelium Blood. 134: 2476-2476. DOI: 10.1182/Blood-2019-130789 |
0.472 |
|
| 2019 |
Rasko JE, Patel A, Griffin JE, Gilleece MH, Radia R, Yeung DT, Slukvin I, Kelly K, Bloor AJ. Results of the First Completed Clinical Trial of an iPSC-Derived Product: CYP-001 in Steroid-Resistant Acute GvHD Biology of Blood and Marrow Transplantation. 25: S255-S256. DOI: 10.1016/J.Bbmt.2018.12.258 |
0.391 |
|
| 2018 |
Kumar A, Lee JH, Suknuntha K, D'Souza SS, Thakur AS, Slukvin II. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30578305 DOI: 10.4049/Jimmunol.1801027 |
0.77 |
|
| 2018 |
Slukvin II, Uenishi GI. Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in hPSC cultures. Experimental Hematology. PMID 30500414 DOI: 10.1016/j.exphem.2018.11.007 |
0.433 |
|
| 2018 |
Park MA, Jung HS, Slukvin I. Genetic Engineering of Human Pluripotent Stem Cells Using PiggyBac Transposon System. Current Protocols in Stem Cell Biology. e63. PMID 30281932 DOI: 10.1002/Cpsc.63 |
0.458 |
|
| 2018 |
Slukvin II, Kumar A. The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells. Cellular and Molecular Life Sciences : Cmls. PMID 29992471 DOI: 10.1007/S00018-018-2871-3 |
0.504 |
|
| 2018 |
Kang H, Mesquitta WT, Jung HS, Moskvin OV, Thomson JA, Slukvin II. GATA2 Is Dispensable for Specification of Hemogenic Endothelium but Promotes Endothelial-to-Hematopoietic Transition. Stem Cell Reports. PMID 29861167 DOI: 10.1016/J.Stemcr.2018.05.002 |
0.437 |
|
| 2018 |
Park MA, Kumar A, Jung HS, Uenishi G, Moskvin OV, Thomson JA, Slukvin II. Activation of the Arterial Program Drives Development of Definitive Hemogenic Endothelium with Lymphoid Potential. Cell Reports. 23: 2467-2481. PMID 29791856 DOI: 10.1016/J.Celrep.2018.04.092 |
0.417 |
|
| 2018 |
Uenishi GI, Jung HS, Kumar A, Park MA, Hadland BK, McLeod E, Raymond M, Moskvin O, Zimmerman CE, Theisen DJ, Swanson S, J Tamplin O, Zon LI, Thomson JA, Bernstein ID, ... Slukvin II, et al. NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nature Communications. 9: 1828. PMID 29739946 DOI: 10.1038/S41467-018-04134-7 |
0.427 |
|
| 2018 |
D'Souza SS, Kumar A, Slukvin II. Functional Heterogeneity of Endothelial Cells Derived from Human Pluripotent Stem Cells. Stem Cells and Development. PMID 29583085 DOI: 10.1089/Scd.2017.0238 |
0.385 |
|
| 2018 |
Suknuntha K, Tao L, Brok-Volchanskaya V, D'Souza SS, Kumar A, Slukvin I. Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Reviews. PMID 29520567 DOI: 10.1007/S12015-018-9805-1 |
0.775 |
|
| 2018 |
Mesquitta W, Kang H, Wandsnider M, Brok-Volchanskaya V, Suknuntha K, Slukvin I. Pyrimido-Indole Derivative, UM171 Expands Distinct Types of Myeloid and Lymphoid Progenitors from Human Pluripotent Stem Cells Blood. 132: 3835-3835. DOI: 10.1182/Blood-2018-99-118303 |
0.807 |
|
| 2018 |
Bloor A, Patel A, Griffin JE, Gilleece MH, Radia R, Yeung DT, Slukvin I, Kelly K, Rasko JE. A Phase I Trial of iPSC-Derived MSCs (CYP-001) in Steroid-Resistant Acute GvHD Blood. 132: 4562-4562. DOI: 10.1182/Blood-2018-99-110432 |
0.383 |
|
| 2018 |
Mesquitta W, Kang H, Wandsnider M, Suknuntha K, Slukvin I. Pyrimido-Indole Derivative, UM171 Promotes Differentiation and Expansion of Myeloid Progenitors and NK Cells From Human Pluripotent Stem Cells Experimental Hematology. 64: S86-S87. DOI: 10.1016/J.Exphem.2018.06.096 |
0.806 |
|
| 2017 |
Kumar A, D'Souza SS, Moskvin OV, Toh H, Wang B, Zhang J, Swanson S, Guo LW, Thomson JA, Slukvin II. Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts. Cell Reports. 19: 1902-1916. PMID 28564607 DOI: 10.1016/J.Celrep.2017.05.019 |
0.504 |
|
| 2016 |
Eguchi A, Wleklinski MJ, Spurgat MC, Heiderscheit EA, Kropornicka AS, Vu CK, Bhimsaria D, Swanson SA, Stewart R, Ramanathan P, Kamp TJ, Slukvin I, Thomson JA, Dutton JR, Ansari AZ. Reprogramming cell fate with a genome-scale library of artificial transcription factors. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930301 DOI: 10.1073/Pnas.1611142114 |
0.359 |
|
| 2016 |
Jung HS, Uenishi G, Kumar A, Park MA, Raymond M, Fink D, McLeod E, Slukvin I. A human VE-cadherin-tdTomato and CD43-green fluorescent protein dual reporter cell line for study endothelial to hematopoietic transition. Stem Cell Research. 17: 401-405. PMID 27879215 DOI: 10.1016/J.Scr.2016.09.004 |
0.52 |
|
| 2016 |
Suknuntha K, Thita T, Togarrati PP, Ratanachamnong P, Wongtrakoongate P, Srihirun S, Slukvin I, Hongeng S. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. International Journal of Hematology. PMID 27766528 DOI: 10.1007/S12185-016-2116-X |
0.743 |
|
| 2016 |
Hafner AL, Contet J, Ravaud C, Yao X, Villageois P, Suknuntha K, Annab K, Peraldi P, Binetruy B, Slukvin II, Ladoux A, Dani C. Brown-like adipose progenitors derived from human induced pluripotent stem cells: Identification of critical pathways governing their adipogenic capacity. Scientific Reports. 6: 32490. PMID 27577850 DOI: 10.1038/Srep32490 |
0.768 |
|
| 2016 |
Slukvin II. Generating Human Hematopoietic Stem Cells In Vitro: Exploring Endothelial To Hematopoietic Transition As A Portal For Stemness Acquisition. Febs Letters. PMID 27391301 DOI: 10.1002/1873-3468.12283 |
0.518 |
|
| 2016 |
D'Souza SS, Maufort J, Kumar A, Zhang J, Smuga-Otto K, Thomson JA, Slukvin II. GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. Stem Cell Reports. PMID 26805448 DOI: 10.1016/J.Stemcr.2015.12.010 |
0.455 |
|
| 2016 |
Timberlake N, Ozog S, D'souza S, Slukvin I, Catz SD, Snyder S, Torbett BE. 4. β-Deliverin: A Small Molecule for Improving Gene Transfer to Hematopoietic Stem Cells and Probing Mechanisms of Lentiviral Vector Restriction Molecular Therapy. 24: S2-S3. DOI: 10.1016/S1525-0016(16)32813-1 |
0.432 |
|
| 2016 |
Uenishi G, McLeod E, Jung HS, Hadland B, Bernstein I, Slukvin I. Regulation of hematoendothelial transition by notch signaling in human pluripotent stem cell cultures Experimental Hematology. 44: S104. DOI: 10.1016/J.Exphem.2016.06.230 |
0.507 |
|
| 2015 |
Elcheva I, Brok-Volchanskaya V, Slukvin I. Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells. Journal of Visualized Experiments : Jove. e52910. PMID 26710184 DOI: 10.3791/52910 |
0.585 |
|
| 2015 |
Kang H, Minder P, Park MA, Mesquitta WT, Torbett BE, Slukvin II. CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus. Molecular Therapy. Nucleic Acids. 4: e268. PMID 26670276 DOI: 10.1038/Mtna.2015.42 |
0.382 |
|
| 2015 |
Suknuntha K, Ishii Y, Tao L, Hu K, McIntosh BE, Yang D, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I. Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Research. 15: 678-693. PMID 26561938 DOI: 10.1016/J.Scr.2015.10.015 |
0.794 |
|
| 2015 |
McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, Thomson JA. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Reports. 4: 171-80. PMID 25601207 DOI: 10.1016/J.Stemcr.2014.12.005 |
0.347 |
|
| 2015 |
D'Souza S, Maufort J, Kumar A, Thomson J, Slukvin I. Efficient Induction of Myleoid and Lymphoid Hematopoiesis from Nonhuman Primate Pluripotent Stem Cells Using GSK3b Inhibitor Blood. 126: 2363-2363. DOI: 10.1182/Blood.V126.23.2363.2363 |
0.572 |
|
| 2014 |
Uenishi G, Theisen D, Lee JH, Kumar A, Raymond M, Vodyanik M, Swanson S, Stewart R, Thomson J, Slukvin I. Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports. 3: 1073-84. PMID 25448067 DOI: 10.1016/J.Stemcr.2014.09.014 |
0.599 |
|
| 2014 |
Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee JH, Tong L, Vodyanik M, Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson JA, Slukvin I. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nature Communications. 5: 4372. PMID 25019369 DOI: 10.1038/Ncomms5372 |
0.572 |
|
| 2014 |
Suknuntha K, Ishii Y, Hu K, Brayan M, Yang DT, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I. Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells Blood. 124: 397-397. DOI: 10.1182/Blood.V124.21.397.397 |
0.796 |
|
| 2014 |
Elcheva I, Brok-Volchanskaya V, Kumar A, Vodyanik M, Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson J, Slukvin I. Identification of two groups of transcriptional regulators directing blood formation from human pluripotent stem cells through distinct types of hemogenic endothelium Experimental Hematology. 42: S60. DOI: 10.1016/J.Exphem.2014.07.228 |
0.516 |
|
| 2013 |
Slukvin II. Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood. 122: 4035-46. PMID 24124087 DOI: 10.1182/blood-2013-07-474825 |
0.526 |
|
| 2013 |
Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang H, Wang T, Lee AY, Swanson SA, Zhang J, ... ... Slukvin I, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 153: 1134-48. PMID 23664764 DOI: 10.1016/J.Cell.2013.04.022 |
0.763 |
|
| 2013 |
Hu K, Slukvin I. Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors. Methods in Molecular Biology (Clifton, N.J.). 997: 163-76. PMID 23546755 DOI: 10.1007/978-1-62703-348-0_13 |
0.538 |
|
| 2013 |
Slukvin II. Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells. Cell Cycle (Georgetown, Tex.). 12: 720-7. PMID 23388453 DOI: 10.4161/cc.23823 |
0.538 |
|
| 2012 |
Bunting KD, Wu P, Slukvin I, McDonald JW. American Journal of Stem Cells: Editorial Board (2012) e-Century Publishing Corporation. American Journal of Stem Cells. 1: 90-1. PMID 23671801 |
0.344 |
|
| 2012 |
Bunting KD, Slukvin I, Wu P, McDonald JW, Wang D. Launching of american journal of stem cells. American Journal of Stem Cells. 1: 1. PMID 23671792 DOI: 10.28967/Jscrt.2016.01.16001 |
0.574 |
|
| 2012 |
Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F, Probasco MD, Tian S, Stewart R, Thomson JA, Slukvin II. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Reports. 2: 553-67. PMID 22981233 DOI: 10.1016/J.Celrep.2012.08.002 |
0.809 |
|
| 2012 |
Slukvin I. Induced Pluripotent Stem Cells and Erythrocyte Production Blood. 120: SCI-38-SCI-38. DOI: 10.1182/Blood.V120.21.Sci-38.Sci-38 |
0.62 |
|
| 2012 |
Hu K, Slukvin I. Induction of Pluripotent Stem Cells from Umbilical Cord Blood Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.201200006 |
0.611 |
|
| 2011 |
Slukvin II. Epicardial origin of cardiac CFU-Fs. Cell Stem Cell. 9: 492-3. PMID 22136919 DOI: 10.1016/j.stem.2011.11.010 |
0.329 |
|
| 2011 |
Salvagiotto G, Burton S, Daigh CA, Rajesh D, Slukvin II, Seay NJ. A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. Plos One. 6: e17829. PMID 21445267 DOI: 10.1371/journal.pone.0017829 |
0.451 |
|
| 2011 |
Slukvin II, Vodyanik M. Endothelial origin of mesenchymal stem cells. Cell Cycle (Georgetown, Tex.). 10: 1370-3. PMID 21444996 DOI: 10.4161/cc.10.9.15345 |
0.52 |
|
| 2011 |
Dias J, Gumenyuk M, Kang H, Vodyanik M, Yu J, Thomson JA, Slukvin II. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells and Development. 20: 1639-47. PMID 21434814 DOI: 10.1089/Scd.2011.0078 |
0.557 |
|
| 2011 |
Choi KD, Vodyanik M, Slukvin II. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nature Protocols. 6: 296-313. PMID 21372811 DOI: 10.1038/nprot.2010.184 |
0.544 |
|
| 2011 |
Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 117: e109-19. PMID 21296996 DOI: 10.1182/Blood-2010-07-298331 |
0.792 |
|
| 2011 |
Suknuntha K, Ishii Y, Hu K, Wang JY, Slukvin I. Modeling CML Development and Drug Resistance Using iPSC Technology, Blood. 118: 3767-3767. DOI: 10.1182/Blood.V118.21.3767.3767 |
0.804 |
|
| 2011 |
Vodyanik M, Togarrati P, Suknuntha K, Choi K, Slukvin I. Identification of Distinct Pathways Involved in Regulation of Mesenchymoangioblasts and Hemangioblasts Development From Mesoderm Blood. 118: 1326-1326. DOI: 10.1182/Blood.V118.21.1326.1326 |
0.776 |
|
| 2011 |
Choi K, Vodyanik M, Tian S, Stewart R, Thomson J, Slukvin I. Identification of Hemogenic Endothelium and Its Direct Precursor in Human Embryonic Stem Cell Differentiation Cultures Blood. 118: 1277-1277. DOI: 10.1182/Blood.V118.21.1277.1277 |
0.503 |
|
| 2010 |
Vodyanik MA, Yu J, Zhang X, Tian S, Stewart R, Thomson JA, Slukvin II. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell. 7: 718-29. PMID 21112566 DOI: 10.1016/J.Stem.2010.11.011 |
0.522 |
|
| 2010 |
Berahovich RD, Zabel BA, Penfold ME, Lewén S, Wang Y, Miao Z, Gan L, Pereda J, Dias J, Slukvin II, McGrath KE, Jaen JC, Schall TJ. CXCR7 protein is not expressed on human or mouse leukocytes. Journal of Immunology (Baltimore, Md. : 1950). 185: 5130-9. PMID 20889540 DOI: 10.4049/Jimmunol.1001660 |
0.32 |
|
| 2010 |
Slukvin II. Generation of mature blood cells from pluripotent stem cells. Haematologica. 95: 1621-3. PMID 20884715 DOI: 10.3324/haematol.2010.029231 |
0.51 |
|
| 2009 |
Slukvin II. Renin-angiotensin system and hemangioblast development from human embryonic stem cells. Expert Review of Hematology. 2: 137-43. PMID 21083448 DOI: 10.1586/ehm.09.4 |
0.534 |
|
| 2009 |
Slukvin II. Neoplastic blood cells become pluripotent. Blood. 114: 5409-10. PMID 20035040 DOI: 10.1182/blood-2009-10-247502 |
0.378 |
|
| 2009 |
Choi KD, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. The Journal of Clinical Investigation. 119: 2818-29. PMID 19726877 DOI: 10.1172/JCI38591 |
0.555 |
|
| 2009 |
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, N.Y.). 324: 797-801. PMID 19325077 DOI: 10.1126/Science.1172482 |
0.5 |
|
| 2009 |
Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, Slukvin I. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 27: 559-67. PMID 19259936 DOI: 10.1634/Stemcells.2008-0922 |
0.561 |
|
| 2008 |
Salvagiotto G, Zhao Y, Vodyanik M, Ruotti V, Stewart R, Marra M, Thomson J, Eaves C, Slukvin I. Molecular profiling reveals similarities and differences between primitive subsets of hematopoietic cells generated in vitro from human embryonic stem cells and in vivo during embryogenesis Experimental Hematology. 36: 1377-1389. PMID 18922365 DOI: 10.1016/J.Exphem.2008.06.015 |
0.616 |
|
| 2008 |
Metallo CM, Vodyanik MA, de Pablo JJ, Slukvin II, Palecek SP. The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnology and Bioengineering. 100: 830-7. PMID 18306423 DOI: 10.1002/Bit.21809 |
0.393 |
|
| 2008 |
Choi K, Yu J, Smuga-Otto K, Dias J, Salvagiotto G, Vodyanik M, Thomson J, Slukvin I. Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Blood. 112: 731-731. DOI: 10.1182/Blood.V112.11.731.731 |
0.583 |
|
| 2007 |
Vodyanik MA, Slukvin II. Directed differentiation of human embryonic stem cells to dendritic cells. Methods in Molecular Biology (Clifton, N.J.). 407: 275-93. PMID 18453262 DOI: 10.1007/978-1-59745-536-7_19 |
0.476 |
|
| 2007 |
Vodyanik MA, Slukvin II. Hematoendothelial differentiation of human embryonic stem cells. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 23.6. PMID 18228507 DOI: 10.1002/0471143030.cb2306s36 |
0.521 |
|
| 2007 |
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science (New York, N.Y.). 318: 1917-20. PMID 18029452 DOI: 10.1126/Science.1151526 |
0.551 |
|
| 2007 |
Rajesh D, Chinnasamy N, Mitalipov SM, Wolf DP, Slukvin I, Thomson JA, Shaaban AF. Differential requirements for hematopoietic commitment between human and rhesus embryonic stem cells. Stem Cells (Dayton, Ohio). 25: 490-9. PMID 17284653 DOI: 10.1634/Stemcells.2006-0277 |
0.565 |
|
| 2006 |
Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 108: 2095-105. PMID 16757688 DOI: 10.1182/Blood-2006-02-003327 |
0.327 |
|
| 2006 |
Slukvin II, Vodyanik MA, Thomson JA, Gumenyuk ME, Choi KD. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. Journal of Immunology (Baltimore, Md. : 1950). 176: 2924-32. PMID 16493050 DOI: 10.4049/Jimmunol.176.5.2924 |
0.426 |
|
| 2006 |
Yu J, Vodyanik MA, He P, Slukvin II, Thomson JA. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells (Dayton, Ohio). 24: 168-76. PMID 16210403 DOI: 10.1634/Stemcells.2005-0292 |
0.52 |
|
| 2005 |
Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 105: 617-26. PMID 15374881 DOI: 10.1182/Blood-2004-04-1649 |
0.502 |
|
| 2004 |
Vodyanik MA, Thomson JA, Slukvin II. CD43 Defines Early Hematopoietic Progenitors Derived from Human Embryonic Stem Cells (hESC). Blood. 104: 3216-3216. DOI: 10.1182/Blood.V104.11.3216.3216 |
0.315 |
|
| 2004 |
Slukvin II, Vodyanik MA, Bork JA, Thomson JA. Development of Lymphohematopoietic Progenitors during Human Embryonic Stem (hES) Cell Differentiation on OP9 Stromal Cells. Blood. 104: 2789-2789. DOI: 10.1182/Blood.V104.11.2789.2789 |
0.468 |
|
| 1994 |
Slukvin II, Chernyshov VP, Merkulova AA, Vodyanik MA, Kalinovsky AK. Differential expression of adhesion and homing molecules by human decidual and peripheral blood lymphocytes in early pregnancy. Cellular Immunology. 158: 29-45. PMID 7522129 DOI: 10.1006/cimm.1994.1254 |
0.308 |
|
| Show low-probability matches. |